EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

A physician-pharmacist partnership intervention for deprescribing (P3iD) among older adults attending a falls and syncope clinic: Protocol for a randomised controlled trial

Sheron Sir Loon Goh, Pauline Siew Mei Lai, Siti Nurkamilla Ramdzan, Kit Mun Tan, Amanda Mae Ching Goh, Maw Pin Tan iD

PLOS One · 03.06.2025 · 20 (6) · e0324565

DOI: 10.1371/journal.pone.0324565 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 03.06.2025. Verfasst von Sheron Sir Loon Goh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Accidental Falls, Deprescriptions, Pharmacists, Physicians. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education Long Term Research Grant, Department of Medicine Research Support Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The concept of deprescribing is gaining traction among clinicians as a formalized approach to improving medication safety for older persons. It has been found to be safe and effective in reducing medication burden. However, its implementation remains challenging. Most research has been conducted in high-income countries, with limited prospective data on deprescribing outcomes in outpatient care settings for older adults in low- and middle-income countries (LMICs). Therefore, evaluating local deprescribing interventions is essential to produce evidence on their effectiveness in older populations. Our study aimed to assess the effectiveness of the Physician-Pharmacist Partnership Intervention for Deprescribing (P3ID) among older persons attending a falls and syncope clinic.

Methods

This randomised controlled trial will be conducted at a teaching hospital in Kuala Lumpur, Malaysia. Participants will involve individuals aged ≥60 years with at least one chronic disease requiring pharmacological treatment, attending the falls and syncope clinic with ≥1 potentially inappropriate medication (PIM) undergoing systematic multidomain assessment and attending physicians at the clinic. The joint pharmacist-physician intervention comprises five steps: 1) PIM identification, 2) decision on cessation and prioritisation, 3) medication withdrawal, 4) monitoring and support, 5) and documentation.

Conclusion

The P3ID trial tests the hypothesis that a jointly led pharmacist-physician intervention in an outpatient will reduce the total number of medications, improve medication adherence, reduce falls and improve patients’ and doctors’ satisfaction towards pharmacist services. Findings from this study would inform future deprescribing practices, particularly in LMIC, pertaining to fall prevention as well as aid the development of future deprescribing interventions in other settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Accidental FallsDeprescriptionsPharmacistsPhysiciansSyncopeAgedAged, 80 and overFemaleHumansMaleMiddle AgedInappropriate PrescribingMalaysiaRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
  • School of Medical and Life Sciences, Sunway University, Sunway, Selangor, Malaysia.
  • Division of Geriatric Medicine, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.

ORCID-Profile: Maw Pin Tan

Förderung

  • Ministry of Higher Education Long Term Research Grant
  • Department of Medicine Research Support Fund

Zitieren

APA

Goh, S. S. L., Lai, P. S. M., Ramdzan, S. N., Tan, K. M., Goh, A. M. C., & Tan, M. P. (2025). A physician-pharmacist partnership intervention for deprescribing (P3iD) among older adults attending a falls and syncope clinic: Protocol for a randomised controlled trial. PLOS One, 20(6), e0324565. https://doi.org/10.1371/journal.pone.0324565

Vancouver

Goh SSL, Lai PSM, Ramdzan SN, Tan KM, Goh AMC, Tan MP. A physician-pharmacist partnership intervention for deprescribing (P3iD) among older adults attending a falls and syncope clinic: Protocol for a randomised controlled trial. PLOS One. 2025;20(6):e0324565. doi:10.1371/journal.pone.0324565

BibTeX
@article{Goh2025,
  author = {Goh, Sheron Sir Loon and Lai, Pauline Siew Mei and Ramdzan, Siti Nurkamilla and Tan, Kit Mun and Goh, Amanda Mae Ching and Tan, Maw Pin},
  title = {A physician-pharmacist partnership intervention for deprescribing (P3iD) among older adults attending a falls and syncope clinic: Protocol for a randomised controlled trial},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {6},
  pages = {e0324565},
  doi = {10.1371/journal.pone.0324565}
}
Kostenlos starten →